Diabetes Medication Actos Linked To Bladder Cancer

The diabetes drug Actos has been linked to bladder cancer.  A lawsuit has already been filed in court against Takeda Pharmaceuticals claiming that its diabetes medication Actos caused the plaintiff’s bladder cancer.  In the lawsuit, the plaintiff alleges that Takeda failed to warn of the risks of bladder cancer connected with Actos and that had there been such a warning the plaintiff would have sought an alternative course of treatment. 

Recent studies have indicated a connection between Actos usage and an increased likelihood of bladder cancer.  The FDA studied data from the first five years of a 10 year Actos safety study begun in 2002 and concluded that risk of bladder cancer was 40 percent higher for patients taking Actos for at least one year.  Doctors in France and Germany have been advised to stop prescribing Actos. If you or a loved one has taken Actos for more than one year, you may have a claim for damages and should contact our attorneys today at 860-667-0839.